Blas Reyes, MD
MOHS-Micrographic Surgery · Miami, FLNPI 1568528081
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for mohs-micrographic surgery clinicians in FL, where the typical reported total is $1,790.
Across 9 payments — averaging $26.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$49
- Lilly USA, LLC$33
- Sun Pharmaceutical Industries Inc.$31
- AbbVie$28
- Incyte Corporation$26
- Johnson & Johnson$24
- plus $47 from 2 others
What the payments were for
- Food & beverage$239100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 2 | $49 |
| Lilly USA, LLC | 1 | $33 |
| Sun Pharmaceutical Industries Inc. | 1 | $31 |
| AbbVie | 1 | $28 |
| Incyte Corporation | 1 | $26 |
| Johnson & Johnson | 1 | $24 |
| UCB, Inc. | 1 | $24 |
| Smith+Nephew | 1 | $23 |
How this compares
$239 in reported general payments places this provider in the 10th percentile of 141 mohs-micrographic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 51 | $3,593 |
| Imiquimod | 51 | $1,488 |
| Mupirocin | 47 | $424 |
| Ketoconazole | 19 | $345 |
| Triamcinolone Acetonide | 34 | $302 |
| Doxycycline Monohydrate | 14 | $179 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Miami
- Jennifer TangMiami$17K
- Peter BittarMiami$3K
- Andrew WeinsteinBoynton Beach$197K
- Armand CognettaTallahassee$139K
- Scott FoskoGainesville$100K
- Paul BenedettoCoral Springs$96K
- Jeremy SunseriPanama City$81K
- Shawna FlanaganJupiter$74K
- Martin ZaiacMiami Beach$61K
- Jason RizzoEstero$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.